Manufacturing guide
How to Choose a Capsule Manufacturer
Choose a capsule manufacturer by testing fit against the actual formulation, filling challenge, quality plan, packaging and market—not by comparing a generic capability list.
Short answer
The right capsule manufacturer is the one whose development, equipment, controls and commercial model fit your specific product. “We make capsules” does not establish competence with a low-density botanical blend, low-dose active, hygroscopic formula, unusual shell or export documentation requirement.
Start with a decision-ready product brief, then evaluate evidence against the risks in that brief. Do not choose from logos, claimed certifications or unit price alone.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Give every manufacturer the same brief
Include formula or ingredient list, raw-material specifications, dose, capsules per serving, target fill weight, shell preference, claims, allergen restrictions, markets, pack, shelf life, forecast and launch quantity. State what is fixed and what remains open.
Without a common brief, quotations are not comparable: one supplier may assume a stock formula and bottle while another includes custom development, validation and a different testing scope.
Technical-fit checklist
| Area | What to establish |
|---|---|
| Formulation | Can the team characterize density, flow, segregation and moisture risk? |
| Shell | Which gelatin/HPMC sizes, grades, colours and printing options can run? |
| Filling | Dosing mechanism and demonstrated fill-weight range for your material |
| Uniformity | Controls for low-dose or segregation-prone blends |
| Moisture | Environment, hold times and experience with hygroscopic fills |
| Scale-up | How pilot observations transfer to the commercial line |
Ask for the proposed manufacturing pathway, not only the equipment list.
Quality and documentation
Confirm legal entity and site, applicable manufacturing authorization, quality-system scope, raw-material qualification, master-record control, deviation and change-control process, test specifications, laboratory arrangement, batch documentation and complaint/recall process.
Certification claims should be tied to the correct legal entity, facility, scope and validity. A logo on a website is not the same as independently verified evidence.
Packaging and stability capability
Ask which bottle and blister systems the site actually runs, component suppliers, line constraints, integrity checks, desiccant handling and stability support. A manufacturer may fill capsules well but lack the package or barrier your product needs. Review the packaging stability framework before treating pack choice as a procurement detail.
Commercial and operating fit
Compare development scope, MOQ definition, material and packaging commitments, testing, lead time, payment milestones, re-order conditions, ownership of formula and specifications, excess inventory and change fees. The capsule economics guide provides a common comparison structure.
Questions that reveal capability
Ask:
- What formulation data do you need before selecting capsule size and process?
- How do you assess flow, density and segregation risk?
- What would make you reject or reformulate this brief?
- Which attributes are monitored during filling?
- How are low-dose ingredients controlled?
- What changes between pilot and commercial scale?
- Which package and stability risks remain unresolved?
- What is excluded from the quotation?
Specific, evidence-based answers are more useful than a broad “end-to-end” claim.
Red flags
Treat universal fill-capacity promises, instant quotations without formula review, unexplained certification claims, refusal to identify the manufacturing site, missing test scope, unclear formula ownership, and a price that omits packaging or quality work as reasons for further diligence—not automatic proof of wrongdoing.
Sources and evidence boundaries
- U.S. Food and Drug Administration, “Current Good Manufacturing Practices for Food and Dietary Supplements.” Official guidance
- Franc, Vetchý and Fülöpová, “Commercially Available Enteric Empty Hard Capsules, Production Technology and Application,” Pharmaceuticals 15 (2022): 1398. Full text
- Stegemann et al., “Application of QbD Principles for the Evaluation of Empty Hard Capsules as an Input Parameter in Formulation Development and Manufacturing,” AAPS PharmSciTech 15 (2014): 542–549. Full text
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
This is a manufacturer-selection framework, not certification or endorsement of any supplier. Capability and compliance must be assessed against current evidence for the actual facility and project.